Table 6 Key indicators and targets for the strategy
Key indicators | Baseline (2016) [5] | Midterm results (2019) [5] | Targets (2020) | Comments/Analysis |
|---|---|---|---|---|
Reduction in cervical cancer age-specific mortality rate | 35.3 per 100,000 | 46 per 100,000* | 33 per 100,000 | Mortality may not decrease initially as reporting gets better |
Reduction in cervical cancer age-specific incidence rate | 56.4 per 100,000 | 86.1 per 100,000 | 52 per 100,000 | Incidence may not decrease initially as reporting gets better due to screening and better surveillance |
Increase in % of women and girls who ever heard about cervical cancer | 76% | No data | 90% | Data can only be obtained through a national survey such as ZDHS |
Increase in % of girls aged 11 years who are vaccinated against HPV | – | 86% | 80% | Overachievement in this indicator is a good sign of commitment towards primary prevention |
Increase in % of women who ever screened for cervical cancer | 13% | No data (national survey) | 50% | Data can only be obtained through a national survey such as ZDHS |
Increase in % of women with precancerous lesions who received treatment. | 53% | 66% | 80% | Significant improvement from the baseline, target realistic. |
Increase in % of women eligible for LEEP or suspected with cervical cancer who access histological investigations | – | No data | 50% | Data collection needs strengthening for this indicator which can feasibly be collected with the right tools |
Increase in % of women with operable cervical cancer who had surgery | – | No data | 10% | Data collection needs strengthening for this indicator which can feasibly be collected with the right tools |
Increase in % of women with cervical cancer who received radiotherapy and chemotherapy services | – | No data | 65% | Data collection needs strengthening for this indicator which can feasibly be collected with the right tools |